Novartis hears pitches to consolidate its agency roster

Share this article:
Novartis has heard pitches for its consumer and professional advertising business with a view toward consolidating its agency roster into 2-4 integrated shops.
The company's global advertising head, Kurt Graves, told Advertising Age that Novartis was torn between seeking global bulk and creative brawn in both consumer and professional. "Nobody has both," Graves told Advertising Age, adding that he had ruled out consolidating Novartis' advertising business into one holding company, as Sanofi-Synthelabo did recently with Publicis Groupe.
Included in the pitch were Deutsch, which handles Lamisil and Zelnorm DTC, Merkley & Partners, which handles Elidel DTC, and Commonhealth Group's Noesis, which handles Elidel and Lotrel professional, as well as non-roster shops such as InChord's GSW Worldwide, DDB Worldwide, Saatchi & Saatchi. 
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.